Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2020 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results

NEWTOWN, Pa., May 14, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
May 11, 2020 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders

NEWTOWN, Pa., May 11, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
May 07, 2020 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020

NEWTOWN, Pa., May 07, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
April 27, 2020 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Strengthens Board of Directors with Nomination of Life Sciences Industry Veteran

NEWTOWN, Pa., April 27, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
March 24, 2020 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Completion of Enrollment of Phase 3 INSPIRE Trial, Provides a Corporate Update, and Reports 2019 Financial Results

NEWTOWN, Pa., March 24, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
March 18, 2020 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Full Year 2019 Financial Results

NEWTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
February 18, 2020 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Participation in Two Upcoming International Conferences

NEWTOWN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with...
February 10, 2020 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present Update at Noble Capital Markets’ Sixteenth Annual Investor Conference in Hollywood, FL

NEWTOWN, Pa., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with...
February 04, 2020 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present Update at the 2020 BIO CEO & Investor Conference in New York City

NEWTOWN, Pa., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with...
January 23, 2020 08:30 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Regains Rigosertib Rights in Greater China

Onconova has the rights to rigosertib, its lead Phase 3 drug candidate, in the key pharmaceutical markets of the United States, Europe, and Greater ChinaThe Company plans to partner certain available...